IRONWOOD PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Ironwood Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2024 was $25M.
  • Ironwood Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $114M.
  • Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$945M, a 478% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was $250M, a 7.78% increase from 2021.
  • Ironwood Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was $232M, a 62.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $114M $25M +$1.11B Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$995M $11M -$49.1M -81.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$945M $37.6M -$30.8M -45% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 -$915M $40M -$28.5M -41.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$886M -$1.08B -$1.14B -2046% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $253M $60.1M +$2.25M +3.89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $250M $68.4M +$11.8M +20.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $239M $68.5M +$3.3M +5.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $235M $55.7M -$9.44M -14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $245M $57.8M +$12.4M +27.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $232M $56.6M +$5.21M +10.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $227M $65.2M +$19.6M +42.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $207M $65.1M +$32.4M +99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $175M $45.4M +$32.2M +243% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $143M $51.4M +$1.79M +3.61% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $141M $45.6M -$20.3M -30.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $161M $32.7M +$11.1M +51.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $150M $13.2M +$30.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $120M $49.6M +$3.15M +6.78% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $117M $65.9M +$212M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$95.5M $21.6M +$36.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$132M -$16.9M +$18.9M +52.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$151M $46.4M -$38.3M -45.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 -$112M -$147M -$127M -654% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $14.8M -$14.7M +$26.3M +64.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$11.5M -$35.9M +$3.84M +9.66% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$15.4M $84.8M +$91.1M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 -$106M -$19.4M +$8.85M +31.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$115M -$41M -$25.7M -168% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$89.6M -$39.7M -$37.7M -1918% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$51.9M -$6.3M -$473K -8.12% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 -$51.4M -$28.3M -$2.1M -8.03% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$49.3M -$15.3M +$26.7M +63.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$76M -$1.97M +$26.1M +93% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$102M -$5.83M +$27.3M +82.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 -$129M -$26.2M +$10.6M +28.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$140M -$42M +$13.1M +23.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$153M -$28.1M +$16.3M +36.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$169M -$33.1M +$13.6M +29.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 -$183M -$36.7M +$19.8M +35% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$203M -$55.1M +$4.76M +7.95% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$208M -$44.4M +$44.4M +50% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$252M -$46.7M -$2.84M -6.47% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 -$249M -$56.6M -$104M -219% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$145M -$59.9M -$19M -46.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$126M -$88.8M -$53.2M -149% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 -$72.8M -$43.9M -$36.9M -524% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-18
Q3 2012 -$35.9M $47.6M +$69.2M Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 -$105M -$40.8M -$21.9M -115% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$83.2M -$35.6M -$17.1M -92.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 -$66.1M -$7.03M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-07
Q3 2011 -$21.6M -$5.45M -33.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$19M -$1.64M -9.49% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$18.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$16.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$17.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.